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ABSTRACT
X-ray repair cross-complementing protein-1
(XRCC1)-de®cient cells are sensitive to DNA damag-
ing agents and have delayed processing of DNA
base lesions. In support of its role in base excision
repair, it was found that XRCC1 forms a tight
complex with DNA ligase IIIa and also interacts with
DNA polymerase b (Pol b) and other base excision
repair (BER) proteins. We have isolated wild-type
XRCC1±DNA ligase IIIa heterodimer and mutated
XRCC1±DNA ligase IIIa complex that does not inter-
act with Pol b and tested their activities in BER
reconstituted with human puri®ed proteins. We ®nd
that a point mutation in the XRCC1 protein which
disrupts functional interaction with Pol b, affected
the ligation ef®ciency of the mutant XRCC1±DNA
ligase IIIa heterodimer in reconstituted BER reac-
tions. We also compared sensitivity to hydrogen
peroxide between wild-type CHO-9 cells, XRCC1-
de®cient EM-C11 cells and EM-C11 cells transfected
with empty plasmid vector or with plasmid vector
carrying wild-type or mutant XRCC1 gene and ®nd
that the plasmid encoding XRCC1 protein, that does
not interact with Pol b has reduced ability to rescue
the hydrogen peroxide sensitivity of XRCC1-
de®cient cells. These data suggest an important role
for the XRCC1±Pol b interaction for coordinating the
ef®ciency of the BER process.
INTRODUCTION
Base excision repair (BER) is the major pathway involved in
removal of endogenous and mutagen induced DNA damage.
This repair process involves a number of sequential reactions
initiated by a damage-speci®c DNA glycosylase that recog-
nizes and removes the damaged base by cleavage of the
N-glycosylic bond connecting the base to the sugar phosphate
backbone. The arising apurinic/apyrimidinic site (AP site)
is recognized by an apurinic/apyrimidinic endonuclease 1
(APE1) that incises the phosphodiester bond 5¢ next to the AP
site, followed by addition of one nucleotide to the 3¢-OH end
of the incised AP site and excision of the base-free sugar
phosphate residue by DNA polymerase b (Pol b). Finally,
DNA ligase completes repair by sealing the DNA ends
(reviewed in 1).
Three major human DNA ligases (DNA ligase I, IIIa and
IV) employ the same basic mechanism for DNA ligation,
but participate in distinct biological processes namely
DNA replication, BER and nonhomologous end joining,
respectively (2). The mechanism linking DNA ligases to a
particular biological process is unclear. It was proposed
that other proteins might support functional diversity of the
DNA ligases (3). Indeed, all of the DNA ligases mentioned
above were found in tight complexes with other proteins.
DNA ligase I forms a complex with PCNA (4), and DNA
ligases IIIa and IV with X-ray cross complementing protein 1
(XRCC1) and XRCC4, respectively (5±7). Mutations in a
DNA ligase partner protein frequently leads to genetic
instability and sensitivity to DNA damaging agents (8±10)
and all attempted knockouts of these genes were embryonic
lethal (11).
Changes in the XRCC1 gene in characterized mutant cell
lines (EM7, EM9, EM-C11 and EM-C12) resulted in
undetectable levels of the XRCC1 protein and reduced (3±5
fold) levels of its counterpart protein, DNA ligase IIIa (12,13).
These changes affect the mutant cells' sensitivity to a number
of DNA damaging agents including alkylating agents and
X-rays, pointing to a de®ciency in the BER pathway. Indeed,
delayed ligation during BER was demonstrated for XRCC1-
de®cient cells (14). Since XRCC1 has no established
biological activity, it was suggested that it might serve as a
scaffold protein recruiting and positioning other components
during BER (15,16). This idea was further supported by the
multiple interactions of human XRCC1 with other BER
proteins including Pol b (15,17), polynucleotide kinase (18),
poly(ADP-ribose) polymerase 1 (PARP-1) (17,19), and APE1
(20). Although the physiological role of XRCC1±PARP-1
(21,22) and XRCC1±DNA ligase IIIa (23) interactions have
been recently demonstrated, there are no such data for other
XRCC1 interactions. In this report, we address the role of the
XRCC1±Pol b interaction.
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MATERIALS AND METHODS
Materials
Synthetic oligodeoxyribonucleotides puri®ed by high-
performance liquid chromatography were obtained from
Midland (8-oxoguanine). [g-32P]ATP (3000 Ci/mmol) was
purchased from Perkin-Elmer Life Sciences.
Two-hybrid analysis
Performed as previously described (18).
Proteins
Recombinant human uracil-DNA glycosylase (UDG) was
puri®ed as described (24). Histidine-tagged human Pol b,
APE1 and DNA ligase IIIawere puri®ed on Ni2+-charged His-
Bind Resin (Novagen, Cambridge, MA) as recommended by
the manufacturer.
Transfection and survival experiments
The mammalian expression construct pcD2EXH, encoding
human XRCC1 protein with a C-terminal decahistidine
af®nity tag, was described previously (5). A mutant derivative
of pcD2EXH containing the V86R mutation was constructed
using the `QuikChange' protocol (Stratagene) and con®rmed
by sequencing. EM-C11 cells were cultured as monolayers in
DMEMmedium and a plasmid containing wild-type or mutant
XRCC1 was introduced into EM-C11 cells using `Fugene 6'
transfection reagent (Roche) according to the manufacturer's
protocol. Stable clones were isolated under G418 (1.5 mg/ml)
selection. Treatment with hydrogen peroxide was performed
in DMEM medium with the indicated concentrations of the
mutagen for 15 min. Colonies that appeared after 8±10 days
were ®xed with methanol, stained with Methylene Blue and
counted. Relative colony formation (%) was expressed as
colonies per treatment level/colonies that appeared in the
control.
Puri®cation of XRCC1±DNA ligase IIIa heterodimer
To purify the XRCC1±DNA ligase IIIa heterodimer, cell
extracts prepared from EM-C11 cells by the method of Tanaka
et al. (25) as modi®ed by Vodenicharov et al. (26) were
brought to 5 mM imidazole and 200 ml of 50% Ni-NTA
agarose slurry (Qiagen) was added. After incubation at 4°C for
1 h, beads were washed ®ve times with 0.5 ml of buffer
containing 50 mM NaH2PO4 pH 8.0, 0.2 M KCl, 40 mM
imidazole and the XRCC1±DNA ligase IIIa heterodimer was
eluted with the same buffer containing 250mM imidazole (33
100 ml), dialysed overnight against buffer containing 25 mM
HEPES±KOH pH 7.9, 2 mM DTT, 12 mM MgCl2, 0.1 mM
EDTA, 17% glycerol and 0.1 M KCl and stored at ±80°C.
DNA ligase activity
DNA ligase activity of the puri®ed DNA ligase IIIa and
XRCC1±DNA ligase IIIa heterodimer was monitored using
a 40mer oligonucleotide duplex containing a 3¢-OH and
5¢-phosphate nick at position 20. Reactions were carried out in
a reaction mixture (10 ml) that contained 45 mM HEPES
pH 7.8, 70 mM KCl, 7.5 mM MgCl2, 0.5 mM EDTA, 1 mM
DTT, 2 mM ATP, 20 mM each of dATP, dGTP, dCTP and
TTP, 0.5 mg/ml BSA, a FAM (6-carboxy¯uorescein)-labelled
oligonucleotide duplex (~5 ng, 0.5 pmol) and the indicated
amount of DNA ligase IIIa or XRCC1±DNA ligase IIIa
heterodimer at 37°C for 20 min. The reaction was stopped by
addition of 10 ml of gel loading buffer (95% formamide,
20 mM EDTA, 0.02% Bromophenol Blue and 0.02% xylene
cyanole). Following incubation at 90°C for 3 min, the reaction
products were separated by electrophoresis on a 20%
denaturing polyacrylamide gel. One unit of DNA ligase
activity was de®ned as the amount of enzyme converting
0.1 pmol of the substrate to a full-length product (40mer) at
37°C within 20 min.
Reconstituted repair assays
The reactions were reconstituted in a reaction mixture (10 ml)
that contained 45 mM HEPES pH 7.8, 70 mM KCl, 7.5 mM
MgCl2, 0.5 mM EDTA, 1 mM DTT, 2 mM ATP, 2 mg/ml
BSA, 20 mM each of dATP, dGTP, dCTP and TTP, and a
FAM (6-carboxy¯uorescein)-labelled 30mer oligonucleotide
duplex containing a uracil residue at position 19 (~5 ng,
0.5 pmol). The reactions were initiated by incubation of the
substrate with UDG (~645 fmol), APE1 (~300 fmol), Pol b
(~50 fmol) and the indicated amount of DNA ligase IIIa or
XRCC1±DNA ligase IIIa heterodimer at 37°C for 20 min. The
reaction was stopped by addition of 10 ml of gel loading
buffer. Following incubation at 90°C for 3 min, the reaction
products were separated by electrophoresis in a 20%
denaturing polyacrylamide gel.
RESULTS
Puri®cation and characterization of XRCC1±DNA ligase
IIIa heterodimer
Recombinant XRCC1 and DNA ligase IIIa were shown to
form a very tight complex resistant to dissociation at a high
salt concentration (12) and it was also demonstrated that the
two proteins co-purify over several chromatographic steps (6)
and can be co-immunoprecipitated from whole cell extracts
(18). To purify XRCC1±DNA ligase IIIa heterodimer, we
used EM-C11 cells that contain a G ® A substitution at
nucleotide 1169 in the XRCC1 gene which leads to a C390®
Y amino acid change in the protein and is located in the
putative functional BRCT1 domain (13). This mutation results
in an undetectable level of XRCC1 protein in these cells
(probably due to instability of the mutated protein) and
reduced amounts of DNA ligase IIIa (12,13). We stably
transfected these cells with wild-type His-tagged XRCC1 and
pulled down the XRCC1±DNA ligase IIIa heterodimer using
Ni-NTA agarose. Western blot analysis revealed that the
pulled down fraction contained both XRCC1 and DNA ligase
IIIa components (Fig. 1A). The complex was also tested and
shown to be active in a DNA ligase activity assay with a
nicked oligonucleotide (Fig. 1C and D). However, since a
Coomassie-stained gel of the heterodimer in addition to
XRCC1 and DNA ligase IIIa also contained several back-
ground protein bands characteristic for non-speci®c binding to
Ni-NTA agarose, the complex was tested for enzymatic
activities that may interfere with BER. We did not ®nd any
substantial activity of DNA polymerase, UDG, AP endo-
nuclease or any other nucleases in a reconstituted repair assay
(data not shown). In control experiments, no ligase activity
could be pulled-down from XRCC1-de®cient cells (EM-C11)
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or HeLa cells containing untagged XRCC1 (data not shown).
Marintchev et al. (27) have recently characterized a number of
XRCC1 point mutations speci®cally disrupting the interaction
of Pol b with the N-terminal domain of XRCC1. To test
whether this interaction is important for the activity of the
XRCC1±DNA ligase IIIa heterodimer in the BER reaction,
we used site-directed mutagenesis to generate a V86R
mutation in a cloned human XRCC1 cDNA (Fig. 2A). Yeast
2-hybrid analysis con®rmed that the V86R mutation
greatly reduced or ablated the interaction with Pol b in vivo
(Fig. 2B). This was indicated by the ability of the wild-type
protein, but not mutated protein, to activate the histidine and
b-galactosidase reporter genes in yeast expressing Pol b. The
mutation in XRCC1 did not affect the interaction of XRCC1
with DNA ligase IIIa, however (data not shown).
Then we stably transfected EM-C11 cells with mutated His-
tagged XRCC1 (XRCC1m) pulled down the XRCC1m±DNA
ligase IIIa heterodimer using Ni-NTA agarose and tested its
DNA ligase activity. The V86R mutation did not affect DNA
ligase activity and the complex proved to be highly active
(Fig. 1D).
Interaction of XRCC1±DNA ligase IIIa with Pol b is
required for ef®cient ligation in reconstituted BER
The potential function of XRCC1 as a scaffold protein has
been discussed in a number of papers and the interaction of
XRCC1 with Pol b was suggested as a possible molecular
basis for such a role (reviewed in 16,18,28), however this
model has not been veri®ed experimentally. To demonstrate
that the V86Rmutation in XRCC1 protein affects the ability of
the mutated XRCC1m±DNA ligase IIIa heterodimer to
function in BER, we tested its DNA ligase activity and its
ability to support BER in a reconstituted repair assay. We
reconstituted short-patch repair of uracil in DNA with puri®ed
human recombinant proteins including UDG, APE1, Pol b and
XRCC1±DNA ligase IIIa or mutated XRCC1m±DNA ligase
IIIa heterodimer. The DNA end-joining activity of the
XRCC1±DNA ligase IIIa heterodimer and XRCC1m±DNA
ligase IIIa was initially measured using a single nick-
containing oligonucleotide (Fig. 1C and D, correspondingly)
and an equal amount of activity units was subsequently used
in the reconstituted reaction (one unit of DNA ligase activity
was de®ned as the amount of enzyme converting 0.1 pmol
of the nicked substrate to full-length product at 37°C within
20 min).
For repair reactions, a 30mer oligonucleotide duplex
containing a single uracil at position 19 was used as a
substrate (Fig. 3A). Incubation of the 30mer substrate (Fig. 3B,
lane 1) with UDG and APE1 leads to generation of the 18mer
labelled product resulting from removal of uracil and incision
of the AP site (Fig. 3B, lane 2). Pol b, when added to the
reaction mixture, continues repair by adding one nucleotide to
the 3¢-end of the incised AP site and simultaneously removing
the 5¢-sugar phosphate, thus generating a substrate for DNA
ligase (Fig. 3B, lane 3). The XRCC1±DNA ligase IIIa
heterodimer stimulated ligation (observed as the 30mer full-
length product) and stimulation depended on the amount of the
heterodimer added (Fig. 3B and D). In contrast, the equivalent
amount (in units of DNA ligase activity) of XRCC1m±DNA
ligase IIIa was about 2±3 fold less ef®cient in reconstituted
Figure 1. Isolation and characterization of XRCC1±DNA ligase IIIa heterodimer. (A) XRCC1±DNA ligase IIIa heterodimer pulled down by Ni-NTA agarose
from EM-C11 cells transfected with His-tagged human XRCC1 was subjected to electrophoresis on a 10% polyacrylamide gel, transferred onto PVDF
membrane, and immunoblotted against XRCC1 (lane 2) or DNA ligase IIIa (lane 3) antibodies. Molecular weight markers are shown on lane 1. (B) Schematic
representation of nick-containing oligonucleotide substrate 5¢-labelled with FAM. (C and D) DNA ligase activity of XRCC1±DNA ligase IIIa heterodimer.
The indicated amount of wild-type (C) or mutated (D) XRCC1±DNA ligase IIIa complex was incubated with nick-containing substrate. Following incubation
for 20 min at 37°C, reactions were stopped by addition of an equal volume of gel loading buffer and after incubation at 90°C for 3 min, the reaction products
were separated by electrophoresis on a 20% denaturing polyacrylamide gel.
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Figure 2. Mutated XRCC1 (V86R) does not interact with Pol b in a yeast two-hybrid system. (A) Schematic representation of human XRCC1. Sites of inter-
action with other BER proteins, the nuclear localization signal (NLS) and site-directed point mutation (V86R) affecting XRCC1-Pol b interaction are
indicated. Adapted from Thompson and West (28). (B) Wild-type and mutant human XRCC1 proteins were examined for interaction with human Pol b by
yeast two-hybrid analysis. Yeast Y190 cells harbouring pACT-Pol b and either pAS-XRCC1WT or pAS-XRCC1V86R were examined for activation of the
histidine and b-galactosidase reporter genes that are indicative of a protein±protein interaction. For this purpose, Y190 cells harbouring these constructs were
plated onto minimal media lacking tryptophan and leucine, to select for the pAS and pACT constructs (`Control'), and also on the above plates additionally
lacking histidine and containing 50 mM 3-aminotriazole to test for protein±protein interaction (`Histidine reporter'). Colonies from the control plates above
were also examined for b-galactosidase activity by colony ®lter assays (`b-gal reporter').
Figure 3. Interaction of XRCC1±DNA ligase IIIa with Pol b is required for ef®cient ligation in reconstituted BER. (A) Schematic representation of the
FAM-5¢-labelled oligonucleotide substrate containing uracil (U). A 33 bp duplex oligonucleotide (5 ng, 500 fmol) containing a uracil residue at position 19
was incubated in reaction buffer containing magnesium, dNTPs, 20 ng (645 fmol) of UDG, 10 ng (300 fmol) of APE1, 2 ng (50 fmol) of Pol b and the
indicated amount of wild-type (B) or mutated (C) XRCC1±DNA ligase IIIa complex. Untreated substrate was loaded on lane 1 of (B) and (C), and the
reaction loaded on lane 2 of (B) contained only UDG and APE1. Following incubation for 20 min at 37°C, reactions were stopped by addition of an equal
volume of gel loading buffer and after incubation at 90°C for 2 min, the reaction products were separated by electrophoresis on a 20% denaturing
polyacrylamide gel. (D) Graphical representation of three independent experiments.
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BER (Fig. 3C and D). We thus concluded that interaction of
the XRCC1±DNA ligase IIIa complex with Pol b is required
for ef®cient DNA ligation.
Disruption of XRCC1±DNA ligase IIIa±Pol b interaction
increases cell sensitivity to hydrogen peroxide
Finally, to address the biological role of this mutation, we
compared sensitivity to hydrogen peroxide between wild-type
CHO-9 cells, EM-C11 cells and EM-C11 cells transfected
with empty plasmid vector and with plasmid vector carrying
wild-type or mutant XRCC1 gene. Western blot analysis
revealed that both clones transfected with the plasmid vector
containing wild-type or mutated XRCC1 express similar
levels of XRCC1, and no XRCC1 was detected in the EM-C11
cells transfected with the empty vector (Fig. 4B). In a
clonogenic survival assay, we found that EM-C11 cells were
approximately 2-fold more sensitive to killing by hydrogen
peroxide than CHO-9 cells (Fig. 4A) and transfection of the
EM-C11 cells with the vector carrying wild-type XRCC1, but
not empty vector, completely rescued the EM-C11 cells
(Fig. 4B). However, cells carrying mutated XRCC1 remained
sensitive to hydrogen peroxide, although not as much as the
EM-C11 cells (Fig. 4B).
DISCUSSION
Unless BER enzymes are organized in a preassembled DNA
repair complex, BER should be a highly coordinated process
to avoid accumulation of repair intermediates, since some of
them, such as single strand breaks introduced by APE1 during
the course of repair, are a major threat to genome integrity and
should be repaired promptly. Recently, several groups
proposed the so-called `passing the baton' model for BER
(1,29,30). According to this model, the complex of a repair
protein with damaged DNA formed at one step of the repair is
recognized by the enzyme involved in the next step. Thus, a
DNA repair intermediate is `handed' from one repair protein
to another without exposure to a cellular milieu. In this model,
interactions of XRCC1 protein with other BER proteins were
suggested to play an important role. XRCC1 interacts with
several enzymes implicated in BER including Pol b (15,17),
PARP-1 (17,19) and DNA ligase IIIa (5±7). While the in vivo
effects of disrupting the interactions with PARP-1 and DNA
ligase IIIa have been characterized previously (21±23), the
biological importance of the Pol b interaction had not been
assessed until now. XRCC1 interacts with the palm-thumb
domain of Pol b via its N-terminal domain (NTD) and this
interaction is therefore distinct from the sites of interaction
with either PARP-1 or DNA ligase IIIa (31). Recently, NMR
chemical shift mapping of the XRCC1 NTD±Pol b interaction
interface has identi®ed several key residues involved in this
protein±protein interaction and their importance has been
con®rmed by site-directed mutagenesis (27,32). We selected
one of the XRCC1 mutants (V86R) for further study since it
has been shown to completely abolish binding of the XRCC1
NTD to Pol b (27). The mutation is located in the ®ve-stranded
b-sheet of the core b-sandwich (33) and disrupts a key
hydrophobic interaction with the Pol b thumb loop without,
crucially, affecting the folding of the NTD (27).
In this study, we provide direct evidence of a biological role
for the interaction of XRCC1±DNA ligase IIIa with Pol b by
analysing the relative ef®ciency of wild-type and non-
interacting mutant XRCC1±DNA ligase IIIa heterodimer in
BER reactions reconstituted with puri®ed human proteins. We
®rst demonstrated that the V86R mutation does not affect the
DNA ligase activity of the mutated XRCC1m±DNA ligase
IIIa heterodimer as measured with a nicked oligonucleotide
duplex substrate (Fig. 1). We then used similar amounts of
DNA ligase activity in reconstituted BER reactions and found
that the XRCC1±DNA ligase IIIa heterodimer, which does
not interact with Pol b, has reduced ability to support BER
(Fig. 3). We further demonstrated that this reduced ability of
mutated heterodimer to function as a DNA ligase in BER is
correlated with a reduced ability of the mutated XRCC1 gene
to rescue the DNA damage-sensitive phenotype of XRCC1-
de®cient cells (Fig. 4). Taken together, our data provide the
®rst evidence that interaction of Pol b with XRCC1±DNA
ligase IIIa heterodimer plays an important role in cellular
defence against DNA damage by supporting ef®cient BER.
Figure 4. Reduced survival after hydrogen peroxide treatment of EM-C11
cells transformed with plasmid expressing mutated XRCC1. (A) Survival of
wild-type (CHO-9) cells and XRCC1-de®cient (EM-C11) cells after expos-
ure to hydrogen peroxide. (B) Survival of EM-C11 cells transfected with
expression plasmid harbouring wild-type XRCC1, V86R mutant XRCC1 or
an empty vector after exposure to hydrogen peroxide. Expression of the
XRCC1 gene in the transfected cell lines used for survival experiments was
veri®ed by running 30 mg whole cell extract proteins on a 10% SDS±polya-
crylamide gel followed by transfer onto a PVDF membrane, and immuno-
blot analysis with the indicated antibodies.
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